Madam Speaker, I am pleased to have this last five minutes of the second hour of debate to make a few closing comments.
My motion is meant to ensure that patients suffering with multiple sclerosis, their families and caregivers have access to good information to help them make the decision on the management of their condition.
I want to be clear that the motion is meant to fill a desperate need for information over the next few months and couple of years until the process that is being gone through now by Health Canada and others is complete. It is also meant to bring attention to the issue so that the process that is taking place now is sped up so that we can lessen the burden of cost and effort on MS patients and others who now travel outside of Canada because they cannot have the liberation therapy procedure completed in Canada.
Motion M-274 would establish an information portal that allows MS sufferers who are considering undergoing liberation therapy treatment outside of Canada to gain anecdotal information from patients who have already had this procedure done. This would allow people who have had the treatment to provide information about the process and the results in various clinics outside of Canada, because the procedure is not available in Canada.
I have had many meetings with constituents throughout my riding of Vegreville—Wainwright, individuals across the country, groups in my constituency, various other players in this whole process, as well as the Minister of Health, representatives from the Canadian Institutes for Health Research, doctors researching MS, doctors who work with MS patients, representatives of the MS Society and many others. I certainly learned a lot about this terrible disease and about this procedure, which really does offer hope.
From these discussions, it has been clear that the CCSVI treatment does work for some people and that it offers hope for many more people. I also want to say that our Conservative government has implemented a comprehensive strategy that is being applied on an accelerated timeline to determine the potential of this procedure.
Our government remains committed to working on clinical trials in Canada and continues to operate at an unprecedented rate in studying the liberation therapy treatment. An action plan was developed in 2010 in order to pinpoint areas for federal action and to ensure questions and concerns raised by Canadian MS patients are addressed. This strategy includes three main actions carried out over the course of the past year and a half: first, supporting research led by CIHR; second, developing a Canadian MS monitoring system; and third, facilitating and sharing research evidence to ensure that individuals living with MS have access to up-to-date information.
What else can we do? First, as members of Parliament, we should be encouraging constituents with MS to participate in the studies on liberation therapy treatment, such as the B.C. CCSVI registry and the Alberta multiple sclerosis initiative. If more patients participate in these programs, it may provide better treatment for patients with MS in the future. This could help provide a stop-gap benefit and the information gleaned could help speed up the approval process at the same time.
Second, it seems very unfortunate that the CCSVI treatment, the treatment using angioplasty or venoplasty to open the veins, or stents in some cases, has actually been attached only to MS because that process is used to open veins for other conditions as well. I believe having it attached to MS has actually slowed the whole process down. It is unfortunate that was not realized before but maybe things still can be sped up if that connection is removed.
Third, we can encourage the College of Physicians and Surgeons to take another look at this procedure to be absolutely certain that this long drawn out process cannot be sped up. I encourage it to have another look at that.
I thank all of my colleagues for speaking to this motion. I want my constituents to know that I will not stop here.